COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock22/10/2025
-   
  Appili Therapeutics to Attend BARDA Innovation Symposium 202522/10/2025
-   
  ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology22/10/2025
-   
  ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group22/10/2025
-   
  Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 202522/10/2025
-   
  BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer22/10/2025
-   
  DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes22/10/2025
-   
  Holland Foundation for Sight Restoration Launches Light After Darkness Fundraising Campaign22/10/2025
-   
  TerrAscend Reschedules November 6th Third Quarter 2025 Earnings Conference Call to Pre-Open from Post-Market Close22/10/2025
-   
  Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine22/10/2025
-   
  LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program22/10/2025
-   
  Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences22/10/2025
-   
  Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek22/10/2025
-   
  R1 Launches Phare, Healthcare’s First Revenue Operating System22/10/2025
-   
  DLH Demonstrates Cybersecurity Excellence with CMMC Level 2 Certification22/10/2025
-   
  Alignment Health Plan Named a 2026 Best Insurance Company for Medicare Advantage Across All Its Markets by U.S. News & World Report22/10/2025
-   
  Synergy CHC (NASDAQ: SNYR) Deepens FOCUSfactor® Expansion with Kroger, PriceSmart & Wakefern — Strengthening U.S., Canada, and Global Reach22/10/2025
-   
  Noah Medical Expands Clinical Evidence for the Galaxy System With Two New Studies Presented at CHEST 202522/10/2025
-   
  CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%22/10/2025
Pages